Humana stock price tumbles 21% after Medicare Advantage rate proposal — what to watch next
Humana shares fell 21.1% to $207.93 in after-hours trading Tuesday after the Centers for Medicare & Medicaid Services proposed a 0.09% average payment increase for Medicare Advantage in 2027, far below analyst expectations. The draft also included stricter rules on diagnosis data. U.S. health insurer stocks dropped sharply, erasing billions in market value. Comments on the proposal are due by Feb. 25.